Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of sus...
Source: BMC Research Notes - Category: Research Authors: Trygve Holm øy, Børre Fevang, David Benee Olsen, Olav Spigset and Lars Bø Tags: Research note Source Type: research